Kairos Pharma, LTD.

KAPA · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 1 employees
45
SEC Filings
$0.4942
Close 2026-06-01
1
Employees

Business Summary

Overview We are a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. We are driven by innovative science to develop novel and transformative drug therapies to treat cancer. Our mission is to advance our portfolio of innovative therapeutics ...

Latest Stock Quote

KAPA 2026-06-01 $0.4942 O:$0.501 H:$0.501388 L:$0.4851 Vol:0.1M VWAP:$0.4938
origin leaf: 6a79b43852c052e53d0848b7b1f06472a62a437014005471012f06cad21ed06f

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014159EDGAR109K words
2025-04-152024-12-310001641172-25-004920EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023276EDGAR19K words
2025-08-122025-06-300001641172-25-023167EDGAR—
2025-05-142025-03-310001641172-25-010089EDGAR—
2024-11-142024-09-300001493152-24-045671EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001493152-26-008435EDGAR1K words
2026-02-260001493152-26-008116EDGAR—
2025-10-150001493152-25-018145EDGAR—
2025-10-070001493152-25-017208EDGAR—
2025-09-180001493152-25-013975EDGAR—
2025-09-110001493152-25-013040EDGAR—
2025-09-030001641172-25-026316EDGAR—
2025-07-150001641172-25-019645EDGAR—
2025-06-120001641172-25-014905EDGAR—
2025-06-030001641172-25-013368EDGAR—

45 total filings indexed. 29 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001962011
TickerKAPA
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.kairospharma.com
Listed2024-09-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 309a829ec7a8fcd5daf6c17e80f8a28bd26ac514f2ae33c6d88ca6b7f2149abb
parent: 84c4d87e6c0fde6ca57e2e426a3776c7a829f663ede9bff5fefe9669f5738b50
content hash: 5da96a663cf6e87e836e29f68332d881241f158edbe1186e1cafd5ea354104eb
signed: 2026-06-02T19:01:37.253Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf